A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Metastatic Appendiceal Adenocarcinoma · Intraperitoneal Paclitaxel

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

MD Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Beth Helmink, MD) · bhelmink@mdanderson.org · 832-696-5784
Contact: Principal Investigator (Beth Helmink, MD)

Study leads

Beth Helmink, MD
Principal Investigator
M.D. Anderson Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Surufatinib and Sintilimab in Combination With Capecitabine for Metastatic Adenocarcinoma of Small Intestine or Appendix Carcinoma

Adenocarcinoma of Small Intestine · Appendix Carcinoma · Metastatic

Abroad (travel likely)RecruitingPHASE2

Guangzhou, China

Genetics of Appendix Cancer Study

Appendix Cancer · Appendiceal Cancer · Appendiceal Neoplasms

Abroad (travel likely)Recruiting

Nashville, United States